Literature DB >> 6435708

Structure-antinociceptive activity studies with neurotensin.

S Furuta, K Kisara, S Sakurada, T Sakurada, Y Sasaki, K Suzuki.   

Abstract

The antinociceptive effects of synthetic neurotensin (NT), its fragments and analogues administered into the lateral cerebroventricle have been compared in the conscious mouse. Intracerebroventricular (i.c.v.) administration of NT produced a dose-dependent antinociceptive effect in the tail pressure test. The NT fragments and analogues, NT(8-13), NT(8-10), NT(9-13), NT(9-11), NT(8-11) NHEt and NT(9-11) NHEt were also effective antinociceptive peptides. The potency of NT(8-13) and the duration of its effects were found to be approximately equal to those of NT. The antinociceptive effects produced by NT, NT(8-13) and NT(9-13) were significantly reversed by the opioid antagonist naloxone but not by thyrotropin releasing hormone. It is concluded that NT(8-13) is required for the full expression of the antinociceptive effects of NT which may be mediated in part through the brain opioid system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435708      PMCID: PMC1987165          DOI: 10.1111/j.1476-5381.1984.tb10117.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  The amino acid sequence of a hypothalamic peptide, neurotensin.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

2.  Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli.

Authors:  B V Clineschmidt; J C McGuffin
Journal:  Eur J Pharmacol       Date:  1977-12-15       Impact factor: 4.432

3.  Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes.

Authors:  G R Uhl; J P Bennett; S H Snyder
Journal:  Brain Res       Date:  1977-07-15       Impact factor: 3.252

Review 4.  Neurotensin, a biologically active peptide.

Authors:  G Bissette; P Manberg; C B Nemeroff; A J Prange
Journal:  Life Sci       Date:  1978-11-27       Impact factor: 5.037

5.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

6.  Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure--activity relationships.

Authors:  P Kitabgi; C Poustis; C Granier; J Van Rietschoten; J Rivier; J L Morgat; P Freychet
Journal:  Mol Pharmacol       Date:  1980-07       Impact factor: 4.436

7.  Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine.

Authors:  C B Nemeroff; A J Osbahr; P J Manberg; G N Ervin; A J Prange
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Selective blockade of neurotensin-induced coronary vessel constriction in perfused rat hearts by a neurotensin analogue.

Authors:  R Quirion; F Rioux; D Regoli; S St-Pierre
Journal:  Eur J Pharmacol       Date:  1980-02-08       Impact factor: 4.432

9.  Head-twitch response induced by tyramine.

Authors:  S Orikasa; S Sakurada; K Kisara
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

10.  Synthesis and activities of neurotensin, and its acid and amide analogs: possible natural occurrence of [Gln4]-neurotensin.

Authors:  K Folkers; D Chang; J Humphries; R Carraway; S E Leeman; C Y Bowers
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

View more
  2 in total

1.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

2.  Neurotensin and Xenin Show Positive Correlations With Perceived Stress, Anxiety, Depressiveness and Eating Disorder Symptoms in Female Obese Patients.

Authors:  Ellen Wölk; Andreas Stengel; Selina Johanna Schaper; Matthias Rose; Tobias Hofmann
Journal:  Front Behav Neurosci       Date:  2021-02-16       Impact factor: 3.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.